Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03020433 · ClinicalTrials.gov registry record · Early Phase 1
Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 37
- Enrollment target
NCT03020433 is a Early Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 37 participants.
The verdict
NCT03020433, a Early Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The investigators ultimate goal is to personalize brain stimulation for stroke so outcomes of the upper limb can be maximized for each individual patient. Several groups including the investigators have recently theorized that personalizing stimulation so as to selectively stimulate iM1 in mild, and cPMd in patients with greater severity would help generalize benefits of stimulation. The investigator premise that variances in expressions of plasticity can explain how to best stratify patients for robust, personalized stimulation.
Interventions
- DEVICE rTMS Contralesional M1
- DEVICE rTMS Contralesional PMC
- DEVICE rTMS Ipsilesional PMC
- DEVICE rTMS sham at Ipsilesional M1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03020433
The ClinicalTrials.gov registry entry for NCT03020433 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which rTMS Contralesional M1 is the first listed.
NCT03020433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03020433 about?
NCT03020433 is a clinical study titled "Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity". The investigators ultimate goal is to personalize brain stimulation for stroke so outcomes of the upper limb can be maximized for each individual patient. Several groups including the investigators have recently theorized that personalizing stimulation so as to selectively stimulate iM1 in mild, and...
What is the current status of trial NCT03020433?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 37 participants. The study started on 2016-03. Estimated completion is 2019-12.
What interventions are being tested in trial NCT03020433?
The interventions under investigation include: rTMS Contralesional M1 (DEVICE), rTMS Contralesional PMC (DEVICE), rTMS Ipsilesional PMC (DEVICE), rTMS sham at Ipsilesional M1 (DEVICE).
Who is sponsoring clinical trial NCT03020433?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.